Fabry Disease Treatment Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Fabry Disease Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Enzyme Replacement Therapy (ERT)
1.2.3 Chaperone Treatment
1.2.4 Substrate Reduction Therapy (SRT)
1.2.5 Others
1.3 Market by Application
1.3.1 Global Fabry Disease Treatment Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Fabry Disease Treatment Market Perspective (2017-2028)
2.2 Fabry Disease Treatment Growth Trends by Region
2.2.1 Fabry Disease Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Fabry Disease Treatment Historic Market Size by Region (2017-2022)
2.2.3 Fabry Disease Treatment Forecasted Market Size by Region (2023-2028)
2.3 Fabry Disease Treatment Market Dynamics
2.3.1 Fabry Disease Treatment Industry Trends
2.3.2 Fabry Disease Treatment Market Drivers
2.3.3 Fabry Disease Treatment Market Challenges
2.3.4 Fabry Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Fabry Disease Treatment Players by Revenue
3.1.1 Global Top Fabry Disease Treatment Players by Revenue (2017-2022)
3.1.2 Global Fabry Disease Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Fabry Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Fabry Disease Treatment Revenue
3.4 Global Fabry Disease Treatment Market Concentration Ratio
3.4.1 Global Fabry Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Fabry Disease Treatment Revenue in 2021
3.5 Fabry Disease Treatment Key Players Head office and Area Served
3.6 Key Players Fabry Disease Treatment Product Solution and Service
3.7 Date of Enter into Fabry Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Fabry Disease Treatment Breakdown Data by Type
4.1 Global Fabry Disease Treatment Historic Market Size by Type (2017-2022)
4.2 Global Fabry Disease Treatment Forecasted Market Size by Type (2023-2028)
5 Fabry Disease Treatment Breakdown Data by Application
5.1 Global Fabry Disease Treatment Historic Market Size by Application (2017-2022)
5.2 Global Fabry Disease Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Fabry Disease Treatment Market Size (2017-2028)
6.2 North America Fabry Disease Treatment Market Size by Country (2017-2022)
6.3 North America Fabry Disease Treatment Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Fabry Disease Treatment Market Size (2017-2028)
7.2 Europe Fabry Disease Treatment Market Size by Country (2017-2022)
7.3 Europe Fabry Disease Treatment Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Fabry Disease Treatment Market Size (2017-2028)
8.2 Asia-Pacific Fabry Disease Treatment Market Size by Country (2017-2022)
8.3 Asia-Pacific Fabry Disease Treatment Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Fabry Disease Treatment Market Size (2017-2028)
9.2 Latin America Fabry Disease Treatment Market Size by Country (2017-2022)
9.3 Latin America Fabry Disease Treatment Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Fabry Disease Treatment Market Size (2017-2028)
10.2 Middle East & Africa Fabry Disease Treatment Market Size by Country (2017-2022)
10.3 Middle East & Africa Fabry Disease Treatment Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi S.A.
11.1.1 Sanofi S.A. Company Detail
11.1.2 Sanofi S.A. Business Overview
11.1.3 Sanofi S.A. Fabry Disease Treatment Introduction
11.1.4 Sanofi S.A. Revenue in Fabry Disease Treatment Business (2017-2022)
11.1.5 Sanofi S.A. Recent Development
11.2 Takeda
11.2.1 Takeda Company Detail
11.2.2 Takeda Business Overview
11.2.3 Takeda Fabry Disease Treatment Introduction
11.2.4 Takeda Revenue in Fabry Disease Treatment Business (2017-2022)
11.2.5 Takeda Recent Development
11.3 Amicus Therapeutics Inc.
11.3.1 Amicus Therapeutics Inc. Company Detail
11.3.2 Amicus Therapeutics Inc. Business Overview
11.3.3 Amicus Therapeutics Inc. Fabry Disease Treatment Introduction
11.3.4 Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.3.5 Amicus Therapeutics Inc. Recent Development
11.4 ISU Abxis Co Ltd.
11.4.1 ISU Abxis Co Ltd. Company Detail
11.4.2 ISU Abxis Co Ltd. Business Overview
11.4.3 ISU Abxis Co Ltd. Fabry Disease Treatment Introduction
11.4.4 ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.4.5 ISU Abxis Co Ltd. Recent Development
11.5 JCR Pharmaceuticals Co Ltd.
11.5.1 JCR Pharmaceuticals Co Ltd. Company Detail
11.5.2 JCR Pharmaceuticals Co Ltd. Business Overview
11.5.3 JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Introduction
11.5.4 JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.5.5 JCR Pharmaceuticals Co Ltd. Recent Development
11.6 Protalix Biotherapeutics Inc.
11.6.1 Protalix Biotherapeutics Inc. Company Detail
11.6.2 Protalix Biotherapeutics Inc. Business Overview
11.6.3 Protalix Biotherapeutics Inc. Fabry Disease Treatment Introduction
11.6.4 Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.6.5 Protalix Biotherapeutics Inc. Recent Development
11.7 Idorsia Pharmaceuticals Ltd.
11.7.1 Idorsia Pharmaceuticals Ltd. Company Detail
11.7.2 Idorsia Pharmaceuticals Ltd. Business Overview
11.7.3 Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Introduction
11.7.4 Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.7.5 Idorsia Pharmaceuticals Ltd. Recent Development
11.8 Avrobio Inc.
11.8.1 Avrobio Inc. Company Detail
11.8.2 Avrobio Inc. Business Overview
11.8.3 Avrobio Inc. Fabry Disease Treatment Introduction
11.8.4 Avrobio Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.8.5 Avrobio Inc. Recent Development
11.9 Greenovation Biotech GmbH
11.9.1 Greenovation Biotech GmbH Company Detail
11.9.2 Greenovation Biotech GmbH Business Overview
11.9.3 Greenovation Biotech GmbH Fabry Disease Treatment Introduction
11.9.4 Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2017-2022)
11.9.5 Greenovation Biotech GmbH Recent Development
11.10 Moderna Therapeutics Inc.
11.10.1 Moderna Therapeutics Inc. Company Detail
11.10.2 Moderna Therapeutics Inc. Business Overview
11.10.3 Moderna Therapeutics Inc. Fabry Disease Treatment Introduction
11.10.4 Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022)
11.10.5 Moderna Therapeutics Inc. Recent Development
11.11 Green Cross Pharma Pte Ltd.
11.11.1 Green Cross Pharma Pte Ltd. Company Detail
11.11.2 Green Cross Pharma Pte Ltd. Business Overview
11.11.3 Green Cross Pharma Pte Ltd. Fabry Disease Treatment Introduction
11.11.4 Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2017-2022)
11.11.5 Green Cross Pharma Pte Ltd. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Fabry Disease Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Enzyme Replacement Therapy (ERT)
Table 3. Key Players of Chaperone Treatment
Table 4. Key Players of Substrate Reduction Therapy (SRT)
Table 5. Key Players of Others
Table 6. Global Fabry Disease Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Fabry Disease Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Fabry Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Fabry Disease Treatment Market Share by Region (2017-2022)
Table 10. Global Fabry Disease Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Fabry Disease Treatment Market Share by Region (2023-2028)
Table 12. Fabry Disease Treatment Market Trends
Table 13. Fabry Disease Treatment Market Drivers
Table 14. Fabry Disease Treatment Market Challenges
Table 15. Fabry Disease Treatment Market Restraints
Table 16. Global Fabry Disease Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Fabry Disease Treatment Market Share by Players (2017-2022)
Table 18. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2021)
Table 19. Ranking of Global Top Fabry Disease Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Fabry Disease Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Fabry Disease Treatment Product Solution and Service
Table 23. Date of Enter into Fabry Disease Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Fabry Disease Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Fabry Disease Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Fabry Disease Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Fabry Disease Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Fabry Disease Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Fabry Disease Treatment Revenue Market Share by Application (2017-2022)
Table 31. Global Fabry Disease Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Fabry Disease Treatment Revenue Market Share by Application (2023-2028)
Table 33. North America Fabry Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Fabry Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Fabry Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Fabry Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Fabry Disease Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Fabry Disease Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Fabry Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Fabry Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Fabry Disease Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Fabry Disease Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 43. Sanofi S.A. Company Detail
Table 44. Sanofi S.A. Business Overview
Table 45. Sanofi S.A. Fabry Disease Treatment Product
Table 46. Sanofi S.A. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 47. Sanofi S.A. Recent Development
Table 48. Takeda Company Detail
Table 49. Takeda Business Overview
Table 50. Takeda Fabry Disease Treatment Product
Table 51. Takeda Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 52. Takeda Recent Development
Table 53. Amicus Therapeutics Inc. Company Detail
Table 54. Amicus Therapeutics Inc. Business Overview
Table 55. Amicus Therapeutics Inc. Fabry Disease Treatment Product
Table 56. Amicus Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 57. Amicus Therapeutics Inc. Recent Development
Table 58. ISU Abxis Co Ltd. Company Detail
Table 59. ISU Abxis Co Ltd. Business Overview
Table 60. ISU Abxis Co Ltd. Fabry Disease Treatment Product
Table 61. ISU Abxis Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 62. ISU Abxis Co Ltd. Recent Development
Table 63. JCR Pharmaceuticals Co Ltd. Company Detail
Table 64. JCR Pharmaceuticals Co Ltd. Business Overview
Table 65. JCR Pharmaceuticals Co Ltd. Fabry Disease Treatment Product
Table 66. JCR Pharmaceuticals Co Ltd. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 67. JCR Pharmaceuticals Co Ltd. Recent Development
Table 68. Protalix Biotherapeutics Inc. Company Detail
Table 69. Protalix Biotherapeutics Inc. Business Overview
Table 70. Protalix Biotherapeutics Inc. Fabry Disease Treatment Product
Table 71. Protalix Biotherapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 72. Protalix Biotherapeutics Inc. Recent Development
Table 73. Idorsia Pharmaceuticals Ltd. Company Detail
Table 74. Idorsia Pharmaceuticals Ltd. Business Overview
Table 75. Idorsia Pharmaceuticals Ltd. Fabry Disease Treatment Product
Table 76. Idorsia Pharmaceuticals Ltd. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 77. Idorsia Pharmaceuticals Ltd. Recent Development
Table 78. Avrobio Inc. Company Detail
Table 79. Avrobio Inc. Business Overview
Table 80. Avrobio Inc. Fabry Disease Treatment Product
Table 81. Avrobio Inc. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 82. Avrobio Inc. Recent Development
Table 83. Greenovation Biotech GmbH Company Detail
Table 84. Greenovation Biotech GmbH Business Overview
Table 85. Greenovation Biotech GmbH Fabry Disease Treatment Product
Table 86. Greenovation Biotech GmbH Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 87. Greenovation Biotech GmbH Recent Development
Table 88. Moderna Therapeutics Inc. Company Detail
Table 89. Moderna Therapeutics Inc. Business Overview
Table 90. Moderna Therapeutics Inc. Fabry Disease Treatment Product
Table 91. Moderna Therapeutics Inc. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 92. Moderna Therapeutics Inc. Recent Development
Table 93. Green Cross Pharma Pte Ltd. Company Detail
Table 94. Green Cross Pharma Pte Ltd. Business Overview
Table 95. Green Cross Pharma Pte Ltd. Fabry Disease TreatmentProduct
Table 96. Green Cross Pharma Pte Ltd. Revenue in Fabry Disease Treatment Business (2017-2022) & (US$ Million)
Table 97. Green Cross Pharma Pte Ltd. Recent Development
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Fabry Disease Treatment Market Share by Type: 2021 VS 2028
Figure 2. Enzyme Replacement Therapy (ERT) Features
Figure 3. Chaperone Treatment Features
Figure 4. Substrate Reduction Therapy (SRT) Features
Figure 5. Others Features
Figure 6. Global Fabry Disease Treatment Market Share by Application in 2021 & 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Fabry Disease Treatment Report Years Considered
Figure 11. Global Fabry Disease Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Fabry Disease Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Fabry Disease Treatment Market Share by Region: 2021 VS 2028
Figure 14. Global Fabry Disease Treatment Market Share by Players in 2021
Figure 15. Global Top Fabry Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fabry Disease Treatment as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Fabry Disease Treatment Revenue in 2021
Figure 17. North America Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. North America Fabry Disease Treatment Market Share by Country (2017-2028)
Figure 19. United States Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Canada Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Fabry Disease Treatment Market Share by Country (2017-2028)
Figure 23. Germany Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. France Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. U.K. Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Italy Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Russia Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Nordic Countries Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Fabry Disease Treatment Market Share by Region (2017-2028)
Figure 31. China Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Japan Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. South Korea Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Southeast Asia Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. India Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Australia Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Fabry Disease Treatment Market Share by Country (2017-2028)
Figure 39. Mexico Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Brazil Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Fabry Disease Treatment Market Share by Country (2017-2028)
Figure 43. Turkey Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Saudi Arabia Fabry Disease Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Sanofi S.A. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 46. Takeda Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 47. Amicus Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 48. ISU Abxis Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 49. JCR Pharmaceuticals Co Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 50. Protalix Biotherapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 51. Idorsia Pharmaceuticals Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 52. Avrobio Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 53. Greenovation Biotech GmbH Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 54. Moderna Therapeutics Inc. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 55. Green Cross Pharma Pte Ltd. Revenue Growth Rate in Fabry Disease Treatment Business (2017-2022)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
Industry Market Size
